Genes

AveXis Inc.: Business Systems Analyst

1 hour ago   |   San Diego Biotechnology

AveXis Inc.: OverviewReady to join a team committed to developing and commercializing gene therapies for patients and families devastated by rare neurological gene San Diego...
Read more ...

Genetic Discovery Explains Barley's Sodium Tolerance

16 hours ago   |   ISAAA

A collaboration between plant scientists from the University of Nottingham and Barley Hub at the James Hutton Institute and colleagues in Australia has helped identify a...
Read more ...

Researchers Find Genes to Save Ash Trees from Deadly Beetles

16 hours ago   |   ISAAA

An international research team has identified candidate genes that could help protect ash trees from the Emerald Ash Borer , a deadly pest that is expected to kill billions of...
Read more ...

Sub-region-Specific Optic Nerve Head Glial Activation in Glaucoma

18 hours ago   |   Springer

Abstract Glaucoma, a multifactorial neurodegenerative disease characterized by progressive loss of retinal ganglion cells and their axons in the optic nerve, is a leading cause...
Read more ...

ARTDeco: automatic readthrough transcription detection

19 hours ago   |   BMC Bioinformatics

Mounting evidence suggests several diseases and biological processes target transcription termination to misregulate gene expression. Disruption of transcription termination...
Read more ...

Taming CRISPR's collateral damage

19 hours ago   |   Phys

CRISPR-Cas9 can alter genes at pre-defined sites in specific ways, but it does not always act as planned. An LMU team has now developed a simple method to detect unintended...
Read more ...

QTL‐seq identifies BnaFT.A02 and BnaFLC.A02 as candidates for variation in vernalisation requirement and response in winter oilseed rape

22 hours ago   |   Wiley

Summary Winter, spring and biennial varieties of Brassica napus that vary in vernalisation requirement are grown for vegetable and oil production. Here, we show that the...
Read more ...

Superior haplotypes for haplotype‐based breeding for drought tolerance in pigeonpea

22 hours ago   |   Wiley

Abstract Haplotype‐based breedin g, a recent promising breeding approach to develop tailored made crop varieties deals with identification of superior haplotypes and their...
Read more ...

AveXis Inc.: Research and Development Professionals - Gene Therapy

1 day ago   |   San Diego Biotechnology   |   2 articles

AveXis Inc.: OverviewWe're Growing and looking for talented Research professionals!Ready to join a team committed to moving gene therapies into the clinical and co San Diego...
Read more ...

AveXis Inc.: Associate Director, Development Program Quality Lead

1 day ago   |   San Diego Biotechnology   |   2 articles

AveXis Inc.: OverviewReady to join a team committed to developing and commercializing gene therapies for patients and families devastated by rare neurological gene San Diego...
Read more ...


Register you to post on BioTech Mag

Free Registration

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

2nd International Conference on Tissue Science and Regenerative Medicine

This conference is designed for experts in academia and industries working in the tissue science and regenerative field, this conference will examine cutting-edge research in... Read more ...

AbCellera Raises $105M to Advance Antibody Discovery Operations

AbCellera Raises $105M to Advance Antibody Discovery Operations

Most of the best-selling drugs worldwide today are antibodies, and in the three decades-plus since the first such drug was approved, makers of such treatments have begun... Read more ...

New webinars: Simple Signaling Reporter Assays & Reducing Attrition From...

New webinars: Simple Signaling Reporter Assays & Reducing Attrition From Drug-induced Liver Injury

Xconomy Insight is excited to offer two special webinars to our community this June. Sponsored by Eurofins, registration is free to all. Screening Approaches for Reducing... Read more ...

Gilead Gains Foothold in Solid Tumors With $375M, 10-Year Arcus Bio Pact

Gilead Gains Foothold in Solid Tumors With $375M, 10-Year Arcus Bio Pact

With the year's biggest oncology conference days away, Gilead Sciences is signaling now what its cancer immunotherapy pipeline could look like in the years to come. The drug... Read more ...

Unanswered Questions Drive Convalescent Plasma Research

Unanswered Questions Drive Convalescent Plasma Research

On Saturday, March 14, in southwest Wisconsin, a woman was working in her yard, raking and clearing the first spring weeds. She coughed a bit during the day, and felt some... Read more ...

Merck Outlines COVID-19 Ambitions With Buyout Deal, Collaborations

Merck Outlines COVID-19 Ambitions With Buyout Deal, Collaborations

Merck exited the holiday weekend with some fireworks of its own, announcing three major programs on Tuesday all related to investments in finding ways to treat and prevent... Read more ...

Insitro Adds $143M to Fuel Machine Learning-Driven Drug Development

Insitro Adds $143M to Fuel Machine Learning-Driven Drug Development

A stem cell biologist, a gene editing expert, and a data engineer walk into a room...and that's just a few of the people Daphne Koller has recruited in the past two years to... Read more ...

Site of LUX-ZEPLIN Dark Matter Search Project Carefully Ramps Up Science Work

Site of LUX-ZEPLIN Dark Matter Search Project Carefully Ramps Up Science Work

A photomultiplier tube array that is part of the LUX-ZEPLIN experiment at the Sanford Underground Research Facility in Lead, South Dakota. The photomultiplier tubes are... Read more ...

Viacyte Adds $27M to Move Ahead Trio of Stem Cell Diabetes Treatments

Viacyte Adds $27M to Move Ahead Trio of Stem Cell Diabetes Treatments

Privately held biotech ViaCyte has banked $27 million, the majority an installment of cash from a tranched $80 million Series D financing round it closed in late 2018. The... Read more ...

COVID-19 Sparks New Opportunities for Digital Health Companies

COVID-19 Sparks New Opportunities for Digital Health Companies

Clinicians and regulators are rethinking how healthcare is provided amid precautions prompted by COVID-19. In-person physician visits don't fit within the physical distancing... Read more ...

AveXis Inc.: Business Systems Analyst

AveXis Inc.: OverviewReady to join a team committed to developing and commercializing gene therapies for patients and families devastated by rare neurological gene San Diego... Read more ...